申请人:——
公开号:US20040097507A1
公开(公告)日:2004-05-20
The present invention relates to a compound of Formula (I), which are useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.
1
本发明涉及一种化合物(I)的公式,该化合物对于抑制耐药肿瘤具有用处,其中该耐药性部分或全部由MRP1.1赋予。